These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 25686167)

  • 41. Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts.
    de Las Heras Gala T; Geisel MH; Peters A; Thorand B; Baumert J; Lehmann N; Jöckel KH; Moebus S; Erbel R; Meisinger C; Mahabadi AA; Koenig W;
    PLoS One; 2016; 11(10):e0164688. PubMed ID: 27732641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary Artery Calcium Improves Risk Assessment in Adults With a Family History of Premature Coronary Heart Disease: Results From Multiethnic Study of Atherosclerosis.
    Patel J; Al Rifai M; Blaha MJ; Budoff MJ; Post WS; Polak JF; Bluemke DA; Scheuner MT; Kronmal RA; Blumenthal RS; Nasir K; McEvoy JW
    Circ Cardiovasc Imaging; 2015 Jun; 8(6):e003186. PubMed ID: 26047825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (from MESA).
    Arps K; Rifai MA; Blaha MJ; Michos ED; Nasir K; Yeboah J; Budoff MJ; Blumenthal RS; Bittencourt MS; McEvoy JW
    Am J Cardiol; 2019 Oct; 124(8):1198-1206. PubMed ID: 31416591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.
    Cook NR; Ridker PM
    JAMA Intern Med; 2014 Dec; 174(12):1964-71. PubMed ID: 25285455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis.
    Cao J; Remaley AT; Guan W; Devaraj S; Tsai MY
    Atherosclerosis; 2021 Jun; 327():1-4. PubMed ID: 34004482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.
    Andersson C; Enserro D; Larson MG; Xanthakis V; Vasan RS
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
    Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
    J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.
    Lloyd-Jones DM; Huffman MD; Karmali KN; Sanghavi DM; Wright JS; Pelser C; Gulati M; Masoudi FA; Goff DC
    J Am Coll Cardiol; 2017 Mar; 69(12):1617-1636. PubMed ID: 27825770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond.
    Waite LH; Phan YL; Spinler SA
    J Am Pharm Assoc (2003); 2016; 56(3):284-92. PubMed ID: 27156942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical implications of the American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol for a rural community: Data from the Heart of New Ulm Project.
    Miedema MD; Sidebottom AC; Sillah A; Benson G; Knickelbine T; VanWormer JJ
    J Clin Lipidol; 2017; 11(1):94-101. PubMed ID: 28391916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
    Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
    Bucheit JD; Helsing H; Nadpara P; Virani SS; Dixon DL
    J Clin Lipidol; 2018; 12(2):367-374.e3. PubMed ID: 29277495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Gooding HC; Ning H; Gillman MW; Shay C; Allen N; Goff DC; Lloyd-Jones D; Chiuve S
    JAMA Intern Med; 2017 Sep; 177(9):1354-1360. PubMed ID: 28715555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.
    Zibaeenejad F; Mohammadi SS; Sayadi M; Safari F; Zibaeenezhad MJ
    BMC Cardiovasc Disord; 2022 Apr; 22(1):162. PubMed ID: 35397522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines.
    Dzaye O; Dudum R; Reiter-Brennan C; Kianoush S; Tota-Maharaj R; Cainzos-Achirica M; Blaha MJ
    Prog Cardiovasc Dis; 2019; 62(5):423-430. PubMed ID: 31715194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.